What is the appropriate management for a patient on hemodialysis who develops severe abdominal pain after 45 minutes of treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Severe Abdominal Pain During Hemodialysis: Emergency Management

Stop dialysis immediately and transfer the patient to an acute care setting via EMS for urgent evaluation, as severe abdominal pain during hemodialysis can represent life-threatening conditions including mesenteric ischemia, acute coronary syndrome, or allergic reactions. 1

Immediate Actions

Stop the Dialysis Session

  • Discontinue hemodialysis treatment immediately when severe abdominal pain develops 2, 3
  • The pain may resolve within 60 minutes after stopping dialysis if related to dialysis-specific complications 2
  • Do not attempt to continue or complete the session while investigating the cause

Emergency Transfer and Evaluation

  • Perform a 12-lead ECG immediately before transfer, as myocardial ischemia is the most frequent serious cause of chest/abdominal pain during dialysis 1
  • Transfer by EMS to an acute care setting for comprehensive evaluation 1
  • Dialysis patients have a 2-5% incidence of acute pain during treatment, with multiple potentially life-threatening etiologies 1

Differential Diagnosis to Consider

Life-Threatening Causes (Require Immediate Workup)

Cardiovascular Emergencies:

  • Acute myocardial infarction or acute coronary syndrome (most common serious cause) 1
  • Myocardial ischemia induced by intradialytic hypotension or tachyarrhythmias 1
  • Pericarditis 1

Mesenteric Ischemia:

  • Nonocclusive mesenteric ischemia (NOMI) is a rare but lethal complication in hemodialysis patients 4
  • High index of suspicion required in end-stage renal disease patients with persistent abdominal pain 4
  • CT angiography is the diagnostic test of choice if NOMI is suspected 4
  • Early diagnosis is critical as progressive intestinal ischemia leads to sepsis and death 4

Other Vascular Emergencies:

  • Pulmonary embolism 1
  • Vessel perforation by catheter (rare but serious) 1
  • Embolism 1

Dialysis-Specific Causes

Allergic Reactions:

  • Ethylene oxide reaction from dialyzer sterilization—presents with anxiety, shortness of breath, and abdominal pain within minutes of starting dialysis 3
  • Nafamostat mesilate allergy—causes severe abdominal pain during dialysis when used as anticoagulant 2
  • Eosinophilia may be present (5% or higher) 3
  • Drug lymphocyte stimulation test and antigen-specific IgE can confirm diagnosis 2

Other Dialysis-Related:

  • Hemolysis 1
  • Subclavian steal syndrome 1

Additional Causes

  • Pleuritis 1
  • Gastroesophageal reflux 1
  • Musculoskeletal disorders 1
  • Medication-related (e.g., digoxin toxicity) 5

Diagnostic Approach in Acute Care Setting

Initial Workup

  • 12-lead ECG and cardiac biomarkers to evaluate for ACS 1
  • Complete blood count with differential (check for eosinophilia) 3
  • CT angiography if mesenteric ischemia suspected based on clinical presentation 4
  • Review of anticoagulants used during dialysis (nafamostat mesilate, heparin) 2
  • Assessment of dialyzer sterilization method (ethylene oxide exposure) 3

Key Clinical Features to Assess

  • Timing: pain onset within minutes suggests allergic reaction; after 45 minutes may indicate ischemia 4, 2, 3
  • Associated symptoms: dyspnea, diaphoresis (cardiac), anxiety, shortness of breath (allergic) 1, 3
  • Hemodynamic stability: hypotension during dialysis increases risk of myocardial ischemia 1
  • Recent medication changes: new anticoagulants, cardiac glycosides 2, 5

Management Based on Etiology

If Allergic Reaction Confirmed

  • Switch to ethylene oxide-free dialyzer if ethylene oxide reaction 3
  • Rinse dialyzer with 2 liters of saline before use 3
  • Change anticoagulant from nafamostat mesilate to heparin if drug allergy confirmed 2
  • Consider antihistamines and corticosteroids for acute management

If Mesenteric Ischemia (NOMI) Diagnosed

  • Decrease ultrafiltration rate to reduce hemodynamic stress 4
  • Increase dose of low molecular-weight heparin to prevent thrombosis 4
  • Administer vasoactive drugs to improve mesenteric perfusion 4
  • Partial recovery possible with early intervention; complete resolution requires sustained treatment 4

If Acute Coronary Syndrome

  • Treat as in non-dialysis population with attention to drug clearances 1
  • Percutaneous coronary intervention is preferred over thrombolytic therapy due to increased hemorrhagic risk 1
  • Use antiplatelet agents, beta-blockers, and consider bivalirudin for anticoagulation 1
  • Timing of subsequent dialysis should consider volume status, electrolytes, and bleeding risk 1

Prevention for Future Sessions

Modify Dialysis Prescription

  • Avoid excessive ultrafiltration to prevent hypotension-induced ischemia 1
  • Slow the ultrafiltration rate 1
  • Consider increasing dialysate sodium concentration 1
  • Reduce dialysate temperature 1
  • Ensure adequate anemia correction per guidelines 1

Equipment and Medication Review

  • Document dialyzer type and sterilization method 3
  • Review all anticoagulants and consider alternatives if allergy suspected 2
  • Ensure proper dialyzer rinsing protocols 3

Critical Pitfalls to Avoid

  • Never assume pain is benign or musculoskeletal without ruling out life-threatening causes 1, 4
  • Do not continue dialysis while investigating severe abdominal pain 2, 3
  • Do not delay transfer for extensive in-unit workup; acute care setting evaluation is mandatory 1
  • Maintain high suspicion for NOMI in dialysis patients with persistent abdominal pain, as early diagnosis is critical for survival 4
  • Consider allergic reactions even if patient has tolerated dialysis previously, as sensitization can develop over time 2, 3

References

Related Questions

A 44-year-old male presents with left upper back pain radiating to the axilla; what are the differential diagnoses and appropriate management plan?
What is the appropriate evaluation and management for a 12-year-old female with a one-year history of painless bilateral axillary lymphadenopathy and no other symptoms?
How should a 15-year-old female with recurrent presyncope, tunnel vision, vomiting episodes, and recent headache, and no significant past medical history, be evaluated and managed?
What evaluation and management is recommended for a 21-year-old male with bilateral knee pain that occurs primarily at night and in the morning when it is cold, but not during the day?
What is the most appropriate next step in managing a 45-year-old man with a BMI of 37 who presents with periumbilical pain that has migrated to right lower quadrant tenderness, afebrile, hemodynamically stable, and without nausea, vomiting, bowel habit changes, or urinary symptoms?
Can pregnant women safely take Lexapro (escitalopram)?
How should a single episode of hematuria be evaluated and managed in an incontinent elderly patient?
What is the recommended treatment for peripheral arterial disease?
How long does it typically take for a kidney stone (nephrolith) to migrate from the renal pelvis or calyces into the ureter, becoming a ureterolith?
What are the differences between lercanidipine and amlodipine for the treatment of hypertension, including dosing, efficacy, side effects, and when to choose one over the other?
How should nocturnal enuresis (bedwetting) be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.